Gilead Sciences (GILD)

$66.69 0.10 (0.15%)

16:00 EDT GILD Stock Quote Delayed 30 Minutes

Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?

By Tom Taulli, InvestorPlace Contributor Apr 30, 2019

Gilead has been dead money for some time and with good reason. Still, it seems that much of the bad news is baked into GILD stock.

10 Oversold Stocks to Run From

5 Top Stock Trades for Tuesday: TSLA, TWTR, TTD, O

Don’t Abandon Gilead Stock After Weak Q4 Results

Volume:

Previous Close -

Market Cap 83.62B

PE Ratio 190.54

EPS 0.35

Volume (Avg. Vol.) 4.21M

Day's Range $66.01 - $66.93

52-Week Range $62.07 - $87.86

Dividend & Yield $3.00 (4.50%)

GILD Stock Predictions, Articles, and Gilead Sciences News

9 Blue-Chip Stocks That Will Lose You Money

By James Brumley, InvestorPlace Feature Writer Mar 5, 2019

Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.

Celgene vs. Gilead Stock: What’s the Better Biotech Buy?

By Bret Kenwell, InvestorPlace Contributor Feb 13, 2019

Gilead stock has been stagnating, but there are other choices for investors. How about considering Celgene over GILD stock?

5 Must-See Stock Charts for Wednesday: GILD, NFLX, EA

By Bret Kenwell, InvestorPlace Contributor Feb 12, 2019

Corning, Netflix and Phillips 66 all have brewing breakouts, making them some of our must-see stock charts for Wednesday.

Gilead Sciences Stock Slides Lower on NASH Drug Failure

By William White, InvestorPlace Writer Feb 12, 2019

Gilead Sciences stock was on its way down Tuesday after releasing data from a recent Phase 3 clinical trial concerning its drug selonsertib.

5 Top Stock Trades for Wednesday: GOOGL, GILD, EL, BA

By Bret Kenwell, InvestorPlace Contributor Feb 5, 2019

Alphabet, Gilead Sciences and Estee Lauder all reported earnings. Starbucks and Boeing are breaking out. Here's our top stock trades.

Gilead Sciences Earnings: GILD Stock Dips on Q4 EPS Miss, Revenue Beat

By Karl Utermohlen, InvestorPlace Writer Feb 4, 2019

Gilead Sciences earnings came in below what analysts projected, while revenue beat expectations, but GILD stock declined after hours Monday.

5 of the Best Biotech Stocks to Buy Now

By Ian Bezek, InvestorPlace Contributor Feb 4, 2019

Biotech stocks are off to a hot start in 2019, and these five stocks, in particular, could be the next winners.

7 Stupidly Cheap Stocks to Buy Now

By Harriet Lefton, Writer, TipRanks Jan 22, 2019

If you're looking for bargains, top analysts believe these cheap stocks are a great place to start. Here's what to know.

3 Biopharma Stocks to Buy for Their Robust Dividend Yields

By Tezcan Gecgil, InvestorPlace Contributor Jan 3, 2019

These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.

5 Healthcare Stocks That Are Feeling Sick

By William Roth, InvestorPlace Market Strategist Dec 17, 2018

Healthcare stocks have not avoided the malady that has been dragging the markets down. Here are five that are currently looking rough.

Don’t Punish Gilead Stock for Doing Its Job

By Josh Enomoto, InvestorPlace Contributor Dec 10, 2018

In a turbulent year for Gilead Sciences (NASDAQ:GILD), the company recently generated headlines that will hopefully turn things around for GILD stock. Over the weekend,…

5 Biotech Stocks to Scoop Up for Big Dividends

By Aaron Levitt, InvestorPlace Contributor Nov 27, 2018

Biotech stocks can still pay you some big yields. Here are five of the best dividend stocks in the pharma sector.

8 Best Stocks to Buy for the Holiday Spirit

By Josh Enomoto, InvestorPlace Contributor Nov 19, 2018

Wall Street isn’t necessarily a cutthroat, avaricious platform as these best stocks to buy for the holiday season demonstrate.

Tesaro Stock Sinks in Aftermath of Sale Rumors

By William White, InvestorPlace Writer Nov 19, 2018

Tesaro stock has been on a wild ride these last few days as sales rumors continue to spread about the struggling company.

7 Rising Healthcare Stocks to Consider

By Chris Lau, InvestorPlace Contributor Oct 29, 2018

Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.

Gilead Sciences Stock Is Back to Base — Go Long

By Nicolas Chahine, InvestorPlace Contributor Oct 26, 2018

Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.

Investors Are Underestimating Gilead Sciences Stock

By Chris Lau, InvestorPlace Contributor Oct 24, 2018

GILD stock should benefit as its new products, including treatments for liver cirrhosis and HIV, come to market.

The 5 Best Dividend Stocks to Buy, Hands Down

By Harriet Lefton, Writer, TipRanks Oct 10, 2018

These five dividend stocks boast strong ratings from the Street's best analysts. Best of all, you get long-term dividend returns without compromising.

7 Healthcare Stocks to Buy Right Now

By Ian Bezek, InvestorPlace Contributor Oct 4, 2018

Healthcare stocks face political uncertainty. However, this mix of 7 buys offers broad diversity, and it profits from the aging of America.

5 Reasons to Buy Gilead Stock Today

By Chris Lau, InvestorPlace Contributor Oct 1, 2018

Investors are on the sidelines with Gilead stock, but the wait could be over. A strong pipeline ahead will drive GILD revenue higher.

Gilead Sciences (GILD)

Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?

10 Oversold Stocks to Run From

5 Top Stock Trades for Tuesday: TSLA, TWTR, TTD, O

Don’t Abandon Gilead Stock After Weak Q4 Results

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in